For better therapies through superior medicine, we remain true to our original aspiration. Oriented to clinically benefit patients, we develop innovative drugs with significant therapeutic advantages, address unmet needs against clinical challenge threats, and contribute to the improvement of global public health.

Combining the strategy of self-development and international collaborations, we continue to innovate and strive to become a world-renowned biopharmaceutical company that leads in China, with a focus on not only R&D and manufacturing, but also management and commercialization.